Nutrition Nutrition and Lifestyle Facts

Nutrition fact sheets &
tips to manage sHTG 9,37

If you or a family member has severe hypertriglyceridemia (sHTG), you’ve probably figured out that nutrition plays a key role in managing the disease. The Three P’s of preparation, practice, and positivity can help you save time and eat healthier, as can working with a registered dietitian.

The Three P’s

Preparation: Plan for your success

Having sHTG doesn’t mean you have to say goodbye to foods you love entirely — if you take the time to prepare and have a routine you can stick to. Some ways to plan ahead include:

  • Make a menu for the week ahead and have the right ingredients on hand when it’s time to cook. Build it around the foods you like that may also help you reach your low triglyceride goals, such as:
    • Leafy greens and colorful vegetables
    • Beans, peas, and lentils
    • Non-oily white fish, like cod, skate, haddock, or canned tuna in water
    • Lean proteins, like breast of most poultry (white meat), skinned and trimmed of all fat
    • Most shellfish, including shrimp, squid, and lobster.
    • Egg whites.
    • Fat-free milk, cheese, and plain yogurt.
    • Complex carbohydrates, like whole grain bread and whole grain pasta
    • Herbs and spices; most are non-fat
    • Water, tea, and coffee
  • Read Nutrition Facts food labels so you know what’s inside packaged foods and if you can eat them.
  • Cook food for the week ahead on weekends or days off.
  • Keep healthy snacks around for emergencies. Frozen vegetables that can be quickly steamed in the microwave or prepared snacks like cut up bell peppers or egg whites can help.
  • Read menus online before you dine out, so you don’t feel pressured to choose while at the restaurant. Consider a low-fat snack before you go to keep your hunger in check. It’s also nice to have regular restaurants where the staff knows you and how you like to eat.

Practice: Adopt healthy habits for a lifetime

Repetition builds routine, so eventually your new,
healthier lifestyle will become second nature.

  1. Let others know about sHTG and how they can help. To avoid uncomfortable conversations, some people with sHTG simply explain that they’re “allergic to fat.” While it is not quite accurate, it may help others quickly grasp that sHTG is a serious condition, and that even a tiny bit of fat is not good for you.
  2. When it comes to health, it pays to speak up. Ask for sauces on the side. Remind the chef not to use any oil or butter in cooking. Bring fat-free dressing along for salads.
  3. Eat smaller, more frequent meals. Avoid hunger by eating every 2-3 hours.
  4. Monitor your body’s response. Many foods that help lower triglycerides are high in fiber. If you are not accustomed to eating this way, increase your intake of veggies, fruits, whole grains, and beans gradually, as tolerated.
  5. Keep a water bottle handy. Sometimes our bodies interpret dehydration as hunger, so drink lots of water. Staying hydrated may also reduce the risk of pancreatitis and help with high-fiber diets.

Positivity: Use optimism to your advantage

Instead of dwelling on what you can’t eat or can’t do, discover and embrace “the can” in life.

  1. Spend time cooking with your family or friends. The National Lipid Association has many resources including recipes you can try to make together.
  2. Enjoy every mouthful. Take a bite. Chew slowly. Eating mindfully can create a more satisfying and filling mealtime experience.
  3. Experiment with new flavors and spices. Have fun! You may be surprised and find something you enjoy.

If you have familial chylomicronemia syndrome (FCS), you may have heard about MCT oil

What is MCT oil? 37

MCT oil is a source of fat and calories for people unable to digest or absorb conventional fats. It is usually colorless and has little odor or flavor.

MCT stands for medium-chain triglyceride. MCT oil is absorbed into the bloodstream, but the way it is absorbed differs from other fats such as olive oil or butter.

Although MCT oil is considered an alternative for people who must limit fat intake, it is recommended that MCT oil only be used under medical supervision. If you have FCS, talk to a dietitian about getting a prescription for MCT oil.

Some people cannot tolerate MCT oil, so it should be introduced in small amounts.

What is the difference between MCT oil and coconut oil?

MCT oil and coconut oil are not the same. Although MCT oil is a product of coconut oil, it has been processed and purified to remove fatty acids that are harmful for people who must follow fat restrictive diets.

How do I cook with MCT oil?

There are many different ways to use MCT Oil. It may be mixed into fat-free sauces, salad dressings, and other foods such as whole wheat pasta, brown rice, and vegetables after they are boiled, steamed or baked.

IMPORTANT: MCT oil is not a frying oil because it has a low smoke point. Use low temperatures when cooking with MCT oil.

Where can I purchase MCT oil?

Talk to a registered dietitian about getting a prescription for MCT oil, in order to allow the possibility of insurance coverage and to ensure you get medical-grade MCT oil.

Warning: Certain MCT oils can be purchased on the internet or in conventional grocery stores. These over-the-counter “MCT oils” can be dangerous as they may contain additional additives or fats that may be harmful to people with FCS. If you have FCS, make sure you use only medical-grade MCT oil obtained by a prescription.

Please consult with your registered dietitian and physician before consuming any oil.

Show References
  • 1. Laufs U, Parhofer KG, Ginsberg HN, Hegele RA. Clinical review on triglycerides. Eur Heart J. 2020;41(1):99-109c.
  • 2. Ginsberg HN, Packard CJ, Chapman MJ, Borén J, Aguilar-Salinas CA, Averna M, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021;42(47):4791-806.
  • 3. Virani SS, Morris PB, Agarwala A, Ballantyne CM, Birtcher KK, Kris-Etherton PM, et al. 2021 ACC Expert Consensus Decision Pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: A report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021.
  • 4. Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626-35.
  • 5. Packard CJ. Remnants, LDL, and the quantification of lipoprotein-associated risk in atherosclerotic cardiovascular disease. Curr Atheroscler Rep. 2022;24(1534-6242 (Electronic)):133-42.
  • 6. Wang Y. Higher fasting triglyceride predicts higher risks of diabetes mortality in US adults. Lipids Health Dis. 2021;20(1):181.
  • 7. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285-e350.
  • 8. Chyzhyk V, Brown AS. Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis. Trends Cardiovasc Med. 2020;30(2):80-5.
  • 9. National Lipid Association. Lifestyle changes to reduce triglycerides: Advice from the National Lipid Association Clinician’s Lifestyle Modification Toolbox.
  • 10. Santos-Baez LS, Ginsberg HN. Hypertriglyceridemia-causes, significance, and approaches to therapy. Front Endocrinol (Lausanne). 2020;11:616.
  • 11. Sandesara PB, Virani SS, Fazio S, Shapiro MD. The forgotten lipids: Triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk. Endocr Rev. 2019;40(2):537-57.
  • 12. Carrasquilla GD, Christiansen MR, Kilpeläinen TO. The genetic basis of hypertriglyceridemia. Curr Atheroscler Rep. 2021;23(8):39.
  • 13. Dron JS, Dilliott AA, Lawson A, McIntyre AD, Davis BD, Wang J, et al. Loss-of-function CREB3L3 variants in patients with severe hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2020;40(8):1935-41.
  • 14. Javvaji A, Can AS, Sharma S. Dysbetalipoproteinemia. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.
  • 15. Moulin P, Dufour R, Averna M, Arca M, Cefalù AB, Noto D, et al. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score". Atheroscler. 2018;275:265-72.
  • 16. Nawaz H, Koutroumpakis E, Easler J, Slivka A, Whitcomb DC, Singh VP, et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. Am J Gastroenterol. 2015;110(10):1497-503.
  • 17. Stroes E, Moulin P, Parhofer KG, Rebours V, Löhr JM, Averna M. Diagnostic algorithm for familial chylomicronemia syndrome. Atheroscler Suppl. 2017;23:1-7.
  • 18. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.
  • 19. Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11(9):1201-4.
  • 20. Nivukoski U, Niemelä M, Bloigu A, Bloigu R, Aalto M, Laatikainen T, et al. Combined effects of lifestyle risk factors on fatty liver index. BMC Gastroenterol. 2020;20(1):109.
  • 21. Paquette M, Bernard S. The evolving story of multifactorial chylomicronemia syndrome. Front Cardiovasc Med. 2022;9:886266.
  • 22. Vincent AM, Hinder LM, Pop-Busui R, Feldman EL. Hyperlipidemia: a new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst. 2009;14(4):257-67.
  • 23. Benefits of physical activity: Center for Disease Control and Prevention. [
  • 24. Tari AR, Nauman J, Zisko N, Skjellegrind HK, Bosnes I, Bergh S, et al. Temporal changes in cardiorespiratory fitness and risk of dementia incidence and mortality: a population-based prospective cohort study. Lancet Public Health. 2019;4(11):e565-e74.
  • 25. Whole person health: What you need to know: National Center for Complementary and Integrative Health. [
  • 26. Berglund L, Brunzell J, Sacks FM. Patient information page from The Hormone Foundations. Patient guide to the assessment and treatment of hypertriglyceridemia (high triglycerides). J Clin Endocrinol Metab. 2012;97(9):31a-2a.
  • 27. Ito MK. Chapter 6. Patient-centered care. In: Gogia S, editor. Fundamentals of Telemedicine and Telehealth: Academic Press; 2020:115-126.
  • 28. Barry MJ, Edgman-Levitan S. Shared decision making--pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780-1.
  • 29. Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361-7.
  • 30. Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 2. J Clin Lipidol. 2015;9(6 Suppl):S1-122.e1.
  • 31. Banerji A, Anderson J, Johnston DT. Optimal management of hereditary angioedema: Shared decision-making. J Asthma Allergy. 2021;14:119-25.
  • 32. Zeman H, Cavanaugh E, Metallinos-Katsaras E, Ireland K, Pojednic R. Improved long-term outcomes in high-risk patients receiving registered dietitian nutritionist care. Endocr Metab Sci. 2021;2:100078.
  • 33. Morrell J, Wierzbicki T. 10 Steps before you refer for: Lipids. Br J Cardiol. 2009;16:242-5.
  • 34. Davidson M, Stevenson M, Hsieh A, Ahmad Z, Roeters van Lennep J, Crowson C, et al. The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study. J Clin Lipidol. 2018;12(4):898-907.e2.
  • 35. Lipid Panel: Cleveland Clinic. [
  • 36. Academy of Nutrition and Dietetics. Medical nutrition therapy (MNT) systematic review [

Your are about to leave

You will be taken to a website independently operated and not managed by Ionis Pharmaceuticals. Ionis Pharmaceuticals assumes no responsibility for the content of the site.

Thank you for visiting